help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, T. D.
Right arrow Articles by Pereira, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, T. D.
Right arrow Articles by Pereira, H. A.
(American Journal of Pathology. 2002;160:841-848.)
© 2002 American Society for Investigative Pathology

Regular Articles

CAP37, a Novel Inflammatory Mediator

Its Expression in Endothelial Cells and Localization to Atherosclerotic Lesions

Taunia D. Lee, Melva L. Gonzalez, Padmasini Kumar, Saritha Chary-Reddy, Paula Grammas and H. Anne Pereira

From the Department of Pathology, University of Oklahoma HealthSciences Center, Oklahoma City, Oklahoma

Cationic antimicrobial protein of 37 kd (CAP37), originally isolated from human neutrophils, is an important multifunctional inflammatory mediator. Here we describe its localization within the vascular endothelium associated with atherosclerotic plaques. Evidence from in vitro immunocytochemical, Northern blot, and reverse transcriptase-polymerase chain reaction analysis indicates that CAP37 is induced in endothelial cells in response to inflammatory mediators. Endothelial-derived CAP37 shows sequence identity with an extensive region of neutrophil-derived CAP37. This is the first demonstration of endogenous endothelial CAP37, confirmed by sequence analysis. We suggest that, because of its induction and location in the endothelium and its known monocyte- and endothelial-activating capabilities, CAP37 has potential to modulate monocyte/endothelial dynamics at the vessel wall in inflammation.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
O. Soehnlein, X. Xie, H. Ulbrich, E. Kenne, P. Rotzius, H. Flodgaard, E. E. Eriksson, and L. Lindbom
Neutrophil-Derived Heparin-Binding Protein (HBP/CAP37) Deposited on Endothelium Enhances Monocyte Arrest under Flow Conditions
J. Immunol., May 15, 2005; 174(10): 6399 - 6405.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
H. K. Eltzschig and C. D. Collard
Vascular ischaemia and reperfusion injury
Br. Med. Bull., October 19, 2004; 70(1): 71 - 86.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.